Access to new treatments can be influenced by several factors, including the type and stage of the cancer, availability of clinical trials, insurance coverage, and geographical location. Patients often gain access to cutting-edge treatments through clinical trials, which are research studies that test the efficacy and safety of new therapies. Additionally, some treatments may be available through expanded access programs, which provide experimental treatments to patients who are not eligible for clinical trials.
